This mechanism allows maintenance of the histone H3K27 acetylation (associate with gene expression) at the enhancer loci targeted by MEF2C, a leukemic transcription factor in AML (Figure 3d) [103]. The gene discussed is MEF2C; the disease is acute myeloid leukemia.